Vivakor, Inc. (VIVK) Dividend History

Vivakor, Inc. is a biotechnology company focused on developing and commercializing sustainable environmental and resource recovery solutions. The company specializes in advanced extraction and remediation technologies aimed at mining waste processing, oil and gas waste management, and other environmental applications. Vivakor aims to promote environmentally friendly practices through its innovative solutions.

5220 Spring Valley Rd., Dallas, TX, 75254
Phone: (949) 281-2606
Website: https://www.vivakor.com

Dividend History

Vivakor, Inc. currently does not pay dividends

Company News

  • Vivakor secures $850,000 through loans and notes - Investing.com

    Vivakor, a refuse systems company, has secured $850,000 through loans and convertible promissory notes from an unaffiliated lender and its Chairman, President, and CEO's company. The company has also engaged a consulting firm for advisory and business development services.

    Investing.com
  • Why Stoke Therapeutics Shares Are Trading Higher By Around 70%; Here Are 20 Stocks Moving Premarket

    Shares of Stoke Therapeutics, Inc. (NASDAQ: STOK) rose sharply in today’s pre-market trading after the company announced Phase 1/2a data supporting the potential for STK-001 in Dravet syndrome. Stoke Therapeutics shares jumped 69.7% to $11.03 in pre-market trading Here are some other stocks moving in pre-market trading. Gainers Check-Cap Ltd. (NASDAQ: CHEK) shares gained 38.3% to $2.67 in pre-market trading. Nobul AI Corp entered into business combination agreement with Check-Cap. C3is Inc. (NASDAQ: CISS) rose 35.2% to $0.0476 in pre-market trading. C3is is expected to release its fourth quarter financial results before the opening bell on March 26, 2024. OpGen, Inc. (NASDAQ: OPGN) gained 30.4% to $0.6196 in pre-market trading after the company announced David Lazar will invest $3 million in preferred stock and take over as CEO. Mesoblast Limited (NASDAQ: MESO) gained 23.2% to $2.71 in pre-market trading. Mesoblast was notified by the U.S. FDA that available clinical data from Phase 3 trial appear sufficient to support BLA submission for Remestemcel-L in children with steroid-refractory ...

    Benzinga
    Featured Companies: BREA BZFD CHEK CISS DNUT GWAV INTJ IVVD STOK SXTP TIVC WPRT
  • 5 Penny Stocks To Buy For Under $5 Right Now

    5 penny stocks to buy for less than a large coffee but is the risk worth the reward? The post 5 Penny Stocks To Buy For Under $5 Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

    PennyStocks
    Featured Companies: GBR HSDT REI
Page data last updated 07/23/2025 12:11:48 UTC